Edgewise Therapeutics, Inc. (EWTX) Reports In-Line Q4 EPS
Tweet
Share
E-mailGet Alerts EWTX Hot Sheet
Join SI Premium – FREE
Edgewise Therapeutics, Inc. (NASDAQ: EWTX) reported Q4 EPS of ($0.34), in-line with the analyst estimate of ($0.34).
For earnings history and earnings-related data on Edgewise Therapeutics, Inc. (EWTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citi cuts Micron stock target, sees memory chip prices peaking in 2Q27
- Bimini Capital Management (BMNM) Tops Q2 EPS by 4c
- bioAffinity (BIAF) Tops Q2 EPS by 146c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
